Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fortunato Morabito

Showing results (101-110 of 302) with videos related to

Pageof 31
Sort By:
European Journal of Haematology|January 7, 2025
Advances and Challenges in Quizartinib-Based FLT3 Inhibition for Acute Myeloid Leukemia: Mechanisms of Resistance and Prospective Combination TherapiesAntonella Bruzzese, Enrica Antonia Martino, Caterina Labanca, et al.
Hematological Oncology|October 17, 2023
Tagraxofusp in myeloid malignanciesAntonella Bruzzese, Enrica Antonia Martino, Caterina Labanca, et al.
European Journal of Haematology|May 23, 2009
Serum level of CD26 predicts time to first treatment in early B-chronic lymphocytic leukemiaStefano Molica, Giovanna Digiesi, Rosanna Mirabelli, et al.
Haematologica|November 5, 2002
Feasibility of a mixed inpatient-outpatient model of peripheral blood stem cell transplantation for multiple myelomaFortunato Morabito, Massimo Martino, Caterina Stelitano, et al.
Haematologica|February 22, 2008
Clonal heterogeneity in chronic lymphocytic leukemia cells: superior response to surface IgM cross-linking in CD38, ZAP-70-positive cellsGiovanna Cutrona, Monica Colombo, Serena Matis, et al.
Cancer|September 21, 2004
Clinical relevance of immunophenotype in a retrospective comparative study of 297 peripheral T-cell lymphomas, unspecified, and 496 diffuse large B-cell lymphomas: experience of the Intergruppo Italiano LinformiFortunato Morabito, Andrea Gallamini, Caterina Stelitano, et al.
Expert Opinion on Investigational Drugs|March 3, 2015
Promising therapies for the treatment of chronic lymphocytic leukemiaFortunato Morabito, Anna Grazia Recchia, Ernesto Vigna, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 17, 2017
Long-Term Follow-Up of a Donor versus No-Donor Comparison in Patients with Multiple Myeloma in First Relapse after Failing Autologous TransplantationFrancesca Patriarca, Benedetto Bruno, Hermann Einsele, et al.
American Journal of Hematology|August 5, 2006
High-dose therapy and autologous peripheral blood stem cells transplantation followed by a very low reduced intensity regimen with fludarabine + cyclophosphamide and allograft improve complete remission rate in de novo multiple myeloma patientsMassimo Martino, Giuseppe Console, Giuseppe Irrera, et al.
Cancers|August 28, 2025
Impact of COVID-19 on the Stage and Treatment of Endometrial Cancer: A Cancer Registry Analysis from an Italian Comprehensive Cancer CenterFrancesca Roncaglia, Lucia Mangone, Francesco Marinelli, et al.
Pageof 31

Showing results (101-110 of 302) with videos related to

Sort By:
Pageof 31
European Journal of Haematology|January 7, 2025
Advances and Challenges in Quizartinib-Based FLT3 Inhibition for Acute Myeloid Leukemia: Mechanisms of Resistance and Prospective Combination TherapiesAntonella Bruzzese, Enrica Antonia Martino, Caterina Labanca, et al.
Hematological Oncology|October 17, 2023
Tagraxofusp in myeloid malignanciesAntonella Bruzzese, Enrica Antonia Martino, Caterina Labanca, et al.
European Journal of Haematology|May 23, 2009
Serum level of CD26 predicts time to first treatment in early B-chronic lymphocytic leukemiaStefano Molica, Giovanna Digiesi, Rosanna Mirabelli, et al.
Haematologica|November 5, 2002
Feasibility of a mixed inpatient-outpatient model of peripheral blood stem cell transplantation for multiple myelomaFortunato Morabito, Massimo Martino, Caterina Stelitano, et al.
Haematologica|February 22, 2008
Clonal heterogeneity in chronic lymphocytic leukemia cells: superior response to surface IgM cross-linking in CD38, ZAP-70-positive cellsGiovanna Cutrona, Monica Colombo, Serena Matis, et al.
Cancer|September 21, 2004
Clinical relevance of immunophenotype in a retrospective comparative study of 297 peripheral T-cell lymphomas, unspecified, and 496 diffuse large B-cell lymphomas: experience of the Intergruppo Italiano LinformiFortunato Morabito, Andrea Gallamini, Caterina Stelitano, et al.
Expert Opinion on Investigational Drugs|March 3, 2015
Promising therapies for the treatment of chronic lymphocytic leukemiaFortunato Morabito, Anna Grazia Recchia, Ernesto Vigna, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 17, 2017
Long-Term Follow-Up of a Donor versus No-Donor Comparison in Patients with Multiple Myeloma in First Relapse after Failing Autologous TransplantationFrancesca Patriarca, Benedetto Bruno, Hermann Einsele, et al.
American Journal of Hematology|August 5, 2006
High-dose therapy and autologous peripheral blood stem cells transplantation followed by a very low reduced intensity regimen with fludarabine + cyclophosphamide and allograft improve complete remission rate in de novo multiple myeloma patientsMassimo Martino, Giuseppe Console, Giuseppe Irrera, et al.
Cancers|August 28, 2025
Impact of COVID-19 on the Stage and Treatment of Endometrial Cancer: A Cancer Registry Analysis from an Italian Comprehensive Cancer CenterFrancesca Roncaglia, Lucia Mangone, Francesco Marinelli, et al.
Pageof 31